Skip to Main Content

Paper Details

In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells.
Sci Signal
19
2017
CD107a, CD45, CD56bright), IL-2, IL-2-treated CD56bright NK cells, IL-2-treated CD56dim NK cells, NK, NK cell, NK cell surface, NK cells, NKG2D, Natural killer (NK) cells, activated immune cells, human, human primary NK cells, immature (CD56bright), immature human NK cells, interleukin-2, mature, mature (CD56dim) subsets, virally infected and transformed cells
Author NameAffiliation
William C L StewartBattelle Center for Mathematical Medicine, Research Institute at the Nationwide Children's Hospital
William C L StewartThe Ohio State University
Garry P NolanStanford University
Garry P NolanStanford University
  • 1 - 4

Datasets

Release 1.2